Cephalosporins
Microbial Sensitivity Tests
beta-Lactamases
Cefuroxime
beta-Lactam Resistance
Drug Resistance, Bacterial
Penicillin-Binding Proteins
Acremonium
Gram-Positive Bacterial Infections
Enterococcus faecalis
Drug Resistance, Microbial
Escherichia coli
Plasmids
Drug Resistance
Cephalexin
Ceftriaxone
Cefmenoxime
Ceftizoxime
Drug Resistance, Neoplasm
Bacteria
Penicillin Amidase
Drug Resistance, Multiple, Bacterial
Drug Resistance, Multiple
Cefazolin
Enterobacteriaceae
Cefixime
Penicillins
Disease Resistance
Ceftazidime
Cefamandole
Vascular Resistance
Drug Resistance, Viral
Gram-Negative Bacteria
Enterobacter
Cefonicid
Cefotiam
In vitro activities of cephalosporins and quinolones against Escherichia coli strains isolated from diarrheic dairy calves. (1/261)
The in vitro activities of several cephalosporins and quinolones against 195 strains of Escherichia coli isolated from diary calves affected by neonatal diarrhea were determined. One hundred thirty-seven of these strains produced one or more potential virulence factors (F5, F41, F17, cytotoxic necrotizing factor, verotoxin, and the eae gene), but the remaining 58 strains did not produce any of these factors. From 11 to 18% of the E. coli strains were resistant to cephalothin, nalidixic acid, enoxacin, and enrofloxacin. However, cefuroxime, cefotaxime, and cefquinome were highly effective against the E. coli isolates tested. Some significant differences (P < 0.05) in resistance to quinolones between the strains producing potential virulence factors and nonfimbriated, nontoxigenic, eae-negative strains were found. Thus, eae-positive, necrotoxigenic, and verotoxigenic (except for nalidixic acid) E. coli strains were significantly more sensitive to nalidixic acid, enoxacin, and enrofloxacin than nonfimbriated, nontoxigenic, eae-negative strains. Moreover, eae-positive strains were significantly more sensitive to enoxacin and enrofloxacin than F5-positive strains. Thus, the result of this study suggest that the bovine E. coli strains that produce some potential virulence factors are more sensitive to quinolones than those that do not express these factors. (+info)Use of an oxacillin disk screening test for detection of penicillin- and ceftriaxone-resistant pneumococci. (2/261)
In a context of worldwide emergence of resistance among Streptococcus pneumoniae strains, early detection of strains with decreased susceptibility to beta-lactam antibiotics is important for clinicians. If the 1-microgram oxacillin disk diffusion test is used as described by the National Committee for Clinical Laboratory Standards, no interpretation is available for strains showing zone sizes of /=2.0 microgram/ml) to penicillin. For ceftriaxone, among 98 strains with no zone of inhibition in response to oxacillin, 68 had intermediate resistance (MIC, 1.0 microgram/ml), and 22 were resistant (MIC, >/=2.0 microgram/ml). To optimize the use of the disk diffusion method, we propose that the absence of a zone of inhibition around the 1-microgram oxacillin disk be regarded as an indicator of nonsusceptibility to penicillin and ceftriaxone and recommend that such strains be reported as nonsusceptible to these antimicrobial agents, pending the results of a MIC quantitation method. (+info)Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. (3/261)
With the emergence of beta-lactam antibiotic resistance among strains of Streptococcus pneumoniae, vancomycin has assumed an important role in the treatment of bacterial meningitis. Using the rabbit meningitis model, we evaluated the pharmacokinetics and pharmacodynamics of vancomycin in this setting. Animals were given 80 mg/kg of body weight daily in two or four divided doses to determine the penetration and activity of vancomycin in cerebrospinal fluid (CSF); each regimen was administered with and without dexamethasone. Mean peak (2 h) concentrations in CSF that were four- to eightfold higher than the minimum bactericidal concentration (MBC; 0.5 microgram/ml) for the pathogen were adequate for bacterial clearance. In both groups concentrations in CSF remained higher than the MBC for greater than 80% of the respective dosing intervals, and the penetration of vancomycin into CSF was 20%. Mean concentrations in CSF at 24 to 36 h of therapy were lower than those achieved during the first 12 h, consistent with a decline in the level of antibiotic entry into CSF as inflammation wanes. Rates of bacterial clearance were similar for the two regimens, and for all animals cultures of CSF were sterile by 36 h. The coadministration of dexamethasone significantly reduced the penetration of vancomycin into CSF by 29% and significantly lowered the rate of bacterial clearance during the first 6 h in animals receiving 20-mg/kg doses of vancomycin. For animals receiving 40-mg/kg doses, therapeutic peak concentrations in CSF were obtained even with steroid use, suggesting that the effect of steroids may be circumvented by the use of larger daily doses of vancomycin. (+info)Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli. (4/261)
DNA sequencing data showed that five clinical isolates of Escherichia coli with reduced susceptibility to ceftazidime, ceftriaxone, and cefotaxime contain an ampC gene that is preceded by a strong promoter. Transcription from the strong promoter was 8- to 18-fold higher than that from the promoter from a susceptible isolate. RNA studies showed that mRNA stability does not play a role in the control of AmpC synthesis. (+info)In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates. (5/261)
An important mechanism of bacterial resistance to beta-lactam antibiotics is inactivation by beta-lactam-hydrolyzing enzymes (beta-lactamases). The evolution of the extended-spectrum beta-lactamases (ESBLs) is associated with extensive use of beta-lactam antibiotics, particularly cephalosporins, and is a serious threat to therapeutic efficacy. ESBLs and broad-spectrum beta-lactamases (BDSBLs) are plasmid-mediated class A enzymes produced by gram-negative pathogens, principally Escherichia coli and Klebsiella pneumoniae. MK-0826 was highly potent against all ESBL- and BDSBL-producing K. pneumoniae and E. coli clinical isolates tested (MIC range, 0.008 to 0.12 microgram/ml). In E. coli, this activity was associated with high-affinity binding to penicillin-binding proteins 2 and 3. When the inoculum level was increased 10-fold, increasing the amount of beta-lactamase present, the MK-0826 MIC range increased to 0.008 to 1 microgram/ml. By comparison, similar observations were made with meropenem while imipenem MICs were usually less affected. Not surprisingly, MIC increases with noncarbapenem beta-lactams were generally substantially greater, resulting in resistance in many cases. E. coli strains that produce chromosomal (Bush group 1) beta-lactamase served as controls. All three carbapenems were subject to an inoculum effect with the majority of the BDSBL- and ESBL-producers but not the Bush group 1 strains, implying some effect of the plasmid-borne enzymes on potency. Importantly, MK-0826 MICs remained at or below 1 microgram/ml under all test conditions. (+info)Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein. (6/261)
Three cefoxitin-resistant Escherichia coli isolates from stool specimens of a patient with leukemia were either resistant, intermediate, or sensitive to imipenem. Conjugation experiments showed that cefoxitin resistance, but not imipenem resistance, was transferable. All isolates were shown by isoelectric focusing to produce two beta-lactamases with isoelectric points of 5.4 (TEM-1, confirmed by sequencing of a PCR product) and >8.5 (consistent with a class C beta-lactamase). The gene coding for the unknown beta-lactamase was cloned and sequenced and revealed an enzyme which had 99.9% sequence identity with the plasmid-determined class C beta-lactamase CMY-2. The cloned beta-lactamase gene differed from blaCMY-2 at one nucleotide position that resulted in an amino acid change, tryptophan to arginine at position 221. We propose that this enzyme be designated CMY-4. Both the imipenem-resistant and -intermediate isolates lacked a 38-kDa outer membrane protein (OMP) that was present in the imipenem-sensitive isolate. The lack of an OMP alone did not explain the difference in carbapenem susceptibilities observed. However, measurement of beta-lactamase activities (including measurements under conditions where TEM-1 beta-lactamase was inhibited) indicated that the imipenem-intermediate isolate expressed six- to eightfold less beta-lactamase than did the other isolates. This study illustrates that carbapenem resistance in E. coli can arise from high-level expression of plasmid-mediated class C beta-lactamase combined with an OMP deficiency. Furthermore, in the presence of an OMP deficiency, the level of expression of a plasmid-mediated class C beta-lactamase is an important factor in determining whether E. coli isolates are fully resistant to carbapenems. (+info)Diversity of substitutions within or adjacent to conserved amino acid motifs of penicillin-binding protein 2X in cephalosporin-resistant Streptococcus pneumoniae isolates. (7/261)
The sequence of an approximately 1.1-kb DNA fragment of the pbp2x gene, which encodes the transpeptidase domain, was determined for 35 clinical isolates of Streptococcus pneumoniae for which the cefotaxime (CTX) MICs varied. Strains with substitutions within a conserved amino acid motif changing STMK to SAFK and a Leu-to-Val change just before the KSG motif were highly resistant to CTX (MIC, >==2 microgram/ml). Strains with substitutions adjacent to SSN or KSG motifs had low-level resistance. The amino acid substitutions were plotted on the three-dimensional crystallographic structure of the transpeptidase domain of PBP2X. Transformants containing pbp2x from strains with high-level CTX resistance increased the CTX MIC from 0. 016 microgram/ml to 0.5 to 1.0 microgram/ml. (+info)Efficacy of beta-lactam and inhibitor combinations in a diffusion chamber model in rabbits. (8/261)
Using a diffusion chamber in rabbits, we evaluated therapy with the combination of ceftriaxone plus the beta-lactamase inhibitor tazobactam in comparison with ceftriaxone alone. One sensitive and one resistant strain of Escherichia coli, Enterobacter cloacae and Klebsiella pneumoniae were inoculated into one of the six diffusion chambers, implanted in the same animal. In order to simulate pharmacokinetics in humans, both substances were administered in decreasing doses. Ceftriaxone was given 0, 2, 4 and 6 h after infection in dosages of 45, 35, 25 and 15 mg/kg of body weight, while tazobactam was administered either in one dose at 0 h, or divided into two doses at 0 and 1 h or 0 and 4 h, or divided into three doses at 0, 1 and 4 h after infection. The ratio of ceftriaxone:tazobactam was fixed at 8:1. Ceftriaxone, in combination with tazobactam, given in one dose immediately after infection showed a significant reduction in bacterial count. All other combinations of ceftriaxone and tazobactam did not differ from ceftriaxone in monotherapy. Co-administration of the beta-lactamase inhibitor tazobactam significantly enhanced the activity of ceftriaxone against all three tested species. (+info)Previous article'Etiology' Next article 'Esophageal Cancer'
Some common examples of gram-positive bacterial infections include:
1. Staphylococcus aureus (MRSA) infections: These are infections caused by methicillin-resistant Staphylococcus aureus, which is a type of gram-positive bacteria that is resistant to many antibiotics.
2. Streptococcal infections: These are infections caused by streptococcus bacteria, such as strep throat and cellulitis.
3. Pneumococcal infections: These are infections caused by pneumococcus bacteria, such as pneumonia.
4. Enterococcal infections: These are infections caused by enterococcus bacteria, such as urinary tract infections and endocarditis.
5. Candidiasis: This is a type of fungal infection caused by candida, which is a type of gram-positive fungus.
Gram-positive bacterial infections can be treated with antibiotics, such as penicillin and ampicillin, but the increasing prevalence of antibiotic resistance has made the treatment of these infections more challenging. In some cases, gram-positive bacterial infections may require more aggressive treatment, such as combination therapy with multiple antibiotics or the use of antifungal medications.
Overall, gram-positive bacterial infections can be serious and potentially life-threatening, so it is important to seek medical attention if symptoms persist or worsen over time.
1. Innate immunity: This is the body's first line of defense against infection, and it involves the recognition and elimination of pathogens by cells and proteins that are present from birth.
2. Acquired immunity: This type of immunity develops over time as a result of exposure to pathogens, and it involves the production of antibodies and other immune cells that can recognize and eliminate specific pathogens.
3. Cell-mediated immunity: This is a type of immunity that involves the activation of immune cells, such as T cells and macrophages, to fight off infection.
4. Genetic resistance: Some individuals may have a genetic predisposition to disease resistance, which can be influenced by their ancestry or genetic makeup.
5. Environmental factors: Exposure to certain environmental factors, such as sunlight, clean water, and good nutrition, can also contribute to disease resistance.
Disease resistance is an important concept in the medical field, as it helps to protect against infectious diseases and can reduce the risk of illness and death. Understanding how disease resistance works can help healthcare professionals develop effective strategies for preventing and treating infections, and it can also inform public health policies and interventions aimed at reducing the burden of infectious diseases on individuals and communities.
Some common examples of bacterial infections include:
1. Urinary tract infections (UTIs)
2. Respiratory infections such as pneumonia and bronchitis
3. Skin infections such as cellulitis and abscesses
4. Bone and joint infections such as osteomyelitis
5. Infected wounds or burns
6. Sexually transmitted infections (STIs) such as chlamydia and gonorrhea
7. Food poisoning caused by bacteria such as salmonella and E. coli.
In severe cases, bacterial infections can lead to life-threatening complications such as sepsis or blood poisoning. It is important to seek medical attention if symptoms persist or worsen over time. Proper diagnosis and treatment can help prevent these complications and ensure a full recovery.
Cephalosporin
Discovery and development of cephalosporins
Drug resistance
Cefpirome
Cefozopran
Klebsiella aerogenes
Beta-lactam
Ampicillin
Gonorrhea
Urinary tract infection
Enterobacter
Multidrug-resistant Gram-negative bacteria
Capnocytophaga canimorsus
Cefprozil
Antimicrobial stewardship
Typhoid fever
Plasmid-mediated resistance
Syphilis
Clostridial necrotizing enteritis
Citrobacter
Cefquinome
Beta-lactamase
Drug of last resort
Dichelobacter nodosus
Proteus penneri
Veillonella parvula
Escherichia virus CC31
Cefotaxime
Cefalexin
Neisseria gonorrhoeae
Scarlet fever
Pharmaceutical industry
Alan Hall
Cholestasis
Ceftaroline fosamil
Lysobacter
Penicillium rubens
Meningococcal disease
List of antibiotics
Methicillin-resistant Staphylococcus aureus
Lemierre's syndrome
Gram-negative bacteria
Pseudomonas aeruginosa
Clostridioides difficile
Infection
Vancomycin-resistant Enterococcus
Chicken as food
Pathogenic Escherichia coli
1961 in science
Cardiobacterium hominis
Norfloxacin
Staphylococcus aureus
Pseudomonas stutzeri
Cephalosporin and Ciprofloxacin Resistance in Salmonella, Taiwan - Volume 11, Number 6-June 2005 - Emerging Infectious Diseases...
Cephalosporin resistance Archives - PacBio
Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment...
The use of cephalosporins for gonorrhea: an update on the rising problem of resistance. | Expert Opin Pharmacother;13(10):...
Typhoid fever - Diagnosis and treatment - Mayo Clinic
Publications at this Location : USDA ARS
Advanced Search Results - Public Health Image Library(PHIL)
Bacteroides Infection Treatment & Management: Medical Care, Surgical Care
Plasmids | ScienceBlogs
Frontiers | Characterization and Genome Structure of Virulent Phage EspM4VN to Control Enterobacter sp. M4 Isolated From Plant...
Class 1 and 2 Integrons in Escherichia coli Strains Isolated from Diarrhea and Bacteremia in Children Less Than 2 Years of Age...
Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and...
Antibiogram of S. enterica serovar Typhi and S. enterica serovar Paratyphi A: a multi-centre study from India
Antibiotics in the clinical pipeline in 2011 | The Journal of Antibiotics
Global travellers vulnerable to drug-resistan | EurekAlert!
CVS' Lumbry Park, Axiom Lab and Finn Pathologists investigate antimicrobial resistance in feline urine collected by...
Cefaclor Extended Release Tablets: PI - Drugs.com
Pediatric Pneumonia: Practice Essentials, Background, Pathophysiology
Global Cephalosporin Drugs Market - 2021-2028
Acute and Chronic Paronychia | AAFP
DailyMed - CIPROFLOXACIN- ciprofloxacin hydrochloride tablet, film coated
Aeromonas spp. and Traveler's Diarrhea: Clinical Features and Antimicrobial Resistance - Volume 9, Number 5-May 2003 - Emerging...
Resistance Does Not Greatly Impact Mortality in ICU Patients with HAIs
New information about the epidemiology of MRSP in Finland | University of Helsinki
Prevalence of Penicillin-Resistant Streptococcus pneumoniae -- CT
Fluoroquinolones10
- Resistance to extended-spectrum cephalosporins (ESCs) or fluoroquinolones in Salmonella enterica has become a global concern ( 1 ). (cdc.gov)
- Resistance to fluoroquinolones in Salmonella strains is usually due to the accumulation of mutations in the quinolone resistance-determining regions (QRDRs) of DNA gyrase genes ( 1 , 4 , 5 ). (cdc.gov)
- Resistance to both ESCs and fluoroquinolones remains extremely rare in salmonellae. (cdc.gov)
- In Taiwan, increasing resistance to fluoroquinolones and the emergence of CMY-2-producing ESC-resistant strains in salmonellae have been noted ( 3 - 6 ). (cdc.gov)
- Lineage 1 arose in the late 1970s and the Tn6168/OCL3 clade arose in the late 1990s from an ancestor that had already acquired resistance to third-generation cephalosporins and fluoroquinolones. (pacb.com)
- In 2007, emergence of fluoroquinolone-resistant N. gonorrhoeae in the United States prompted CDC to no longer recommend fluoroquinolones for treatment of gonorrhea, leaving cephalosporins as the only remaining recommended antimicrobial class ( 3 ). (cdc.gov)
- Many of new orally administered antibiotics introduced, such as newer fluoroquinolones or cephalosporins, showed a spectrum of activity and clinical efficacy for the most common clinical community infections. (nih.gov)
- S. intermedius maintains a propensity not to develop resistance to cephalosporins, beta lactamase-resistant penicillins and fluoroquinolones. (vin.com)
- Some of these plasmids contain genes that confer resistance to commonly used antibiotics, including beta-lactam drugs like penicillin and cephalosporins and fluoroquinolones like ciprofloxacin (Cipro). (nih.gov)
- Serious concurrent conditions and prior use of fluoroquinolones, carbapenems, or broad-spectrum cephalosporins have been independently associated with acquisition of infections caused by CRE. (cdc.gov)
Antibiotics19
- The spread of genes coding for resistance determinants among bacteria challenges the use of approved antibiotics, narrowing the options for treatment. (nih.gov)
- Resistance to carbapenems, last resort antibiotics, is a major concern. (nih.gov)
- ESBL enzymes create resistance within the body to most beta-lactam antibiotics, including penicillins, cephalosporins, and aztreonam. (eurekalert.org)
- The prevalence of bacterial strains and their resistance to antibiotics in urine samples from cats in the UK have not been widely reported previously. (vetclick.com)
- Notably, Enterococcus species were frequently found to be resistant to multiple antibiotics, and several other isolates demonstrated resistance to frequently used antibiotics. (vetclick.com)
- The inappropriate use of antibiotics for bacterial cystitis could not only be ineffective to manage bacterial cystitis in cats but promote further antimicrobial resistance. (vetclick.com)
- Even though feline lower urinary tract disease is one of the most common reasons for vets to prescribe antibiotics, the prevalence of bacterial strains in the urine of cats with this condition, and their resistance to commonly used antibiotics, had not been widely studied in the UK to date. (vetclick.com)
- The cephalosporin drugs market growth is driven by the rising demand for anti-microbials in various indications, the increasing prevalence of infectious diseases, the increase in funding for the development of antibiotics, increased consumption of cephalosporin, easier availability, and a rise in demand for over-the-counter drugs. (giiresearch.com)
- This indicates rapid evolution, i.e., gene transfer between strains, which also effectively transfers the genes that convey resistance to antibiotics," he continues. (helsinki.fi)
- What is even more worrying is that resistance towards alternative antibiotics, such as macrolides, lincosamides and tetracycline was between 30% and 40%, so treatment options are becoming fewer and fewer," she maintains. (helsinki.fi)
- A rapid diagnostic test for multi-resistance to broad-spectrum antibiotics has just been developed at the University of Fribourg. (unifr.ch)
- Bacterial resistance to antibiotics has increased considerably over recent years. (unifr.ch)
- Extremely broad-spectrum antibiotics, such as the broad-spectrum cephalosporins and the carbapenems, antibiotics of last resort, are already proving totally ineffective against certain strains of bacteria. (unifr.ch)
- It is estimated that in Europe the total number of deaths associated with multi-resistance to antibiotics is 25,000 annually. (unifr.ch)
- The rapid development of this resistance risks compromising whole areas of 21st century medicine which require effective preventative or curative antibiotics for transplants and major surgery as well as resuscitation. (unifr.ch)
- and it is this carbapenemase activity which is systematically associated with multi-resistance to antibiotics in this type of bacterium (fig. 1). (unifr.ch)
- CONTRAINDICATIONS Keflex is contraindicated in patients with known allergy to the cephalosporin group of antibiotics. (seagullindia.com)
- The most common way that bacteria become invulnerable to antibiotics is through the transfer of resistance genes from other bacteria. (nih.gov)
- Third-generation cephalosporin resistance was calculated as resistance (R) to at least one of the following antibiotics: cefotaxime, ceftriaxone and ceftazidime. (who.int)
Penicillin10
- However, in addition to the B fragilis group, which is resistant to penicillin, other AGNB show increased resistance. (medscape.com)
- Despite their second-line usage, cephalosporins also have a broader spectrum of activity and are more potent than penicillin. (giiresearch.com)
- Most of the Gram positive isolates exhibited higher resistance to penicillin, cephalosporin, macrolides, gentamycin and quinolones. (banglajol.info)
- Almost one in seven bacterial strains (14%) was resistant to methicillin, meaning that treatment with penicillin derivatives or cephalosporins is ineffective. (helsinki.fi)
- Although S. pneumoniae was once considered to be routinely susceptible to penicillin, since the mid-1980s the incidence of resistance of this organism to penicillin and other antimicrobial agents has been increasing in the United States (1-4). (cdc.gov)
- To determine the extent of antimicrobial susceptibility testing of S. pneumoniae and the prevalence of penicillin resistance among pneumococcal isolates from July 1992 through June 1993, in August 1993 the Connecticut Department of Public Health and Addiction Services (DPHAS) surveyed all 44 hospitals with clinical microbiology laboratories in Connecticut. (cdc.gov)
- Hospital laboratories were asked whether pneumococcal isolates were tested for resistance to penicillin, which isolates were tested, which tests were used, the number of isolates tested from different body sites from July 1992 through June 1993, and the minimal inhibitory concentrations (MICs) for any resistant isolates. (cdc.gov)
- Nine laboratories screened pneumococcal isolates by disk diffusion, then confirmed penicillin resistance by determination of a quantitative MIC. (cdc.gov)
- Penicillin resistance was defined as MIC greater than or equal to 0.1 ug/mL, and high-level resistance was defined as MIC greater than or equal to 2.0 ug/mL (5). (cdc.gov)
- Although information regarding resistance to other antimicrobial drugs was unavailable in the Connecticut survey, the overall prevalence of penicillin-resistant strains in Connecticut was low through June 1993. (cdc.gov)
Penicillins2
- Metallo-β-lactamases (MBLs) hydrolyze carbapenems, penicillins, and cephalosporins, becoming central to this problem. (nih.gov)
- Additionally, other Enterobacterales had resistance against cephalosporins and penicillins. (vetclick.com)
Macrolides2
- Empirical treatment with neuraminidase inhibitors and the combination of cephalosporins and macrolides or quinolones are suggested to be an effective treatment for COVID-19. (giiresearch.com)
- Also, the cephalosporins combined with macrolides and quinolones may be potentially effective against COVID-19 (SARS-CoV-2). (giiresearch.com)
Extended-spectrum6
- We report the prevalence and characteristics of Salmonella strains resistant to ciprofloxacin and extended-spectrum cephalosporins in Taiwan from January to May 2004. (cdc.gov)
- All isolates resistant to extended-spectrum cephalosporins carried bla CMY-2 , and all ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis isolates were genetically related. (cdc.gov)
- ESC resistance in Salmonella strains is usually due to the production of plasmid-mediated extended-spectrum β-lactamases (ESBLs) or AmpC β-lactamases, and among these β-lactamases, the CMY-2 AmpC enzyme has been reported most often ( 1 - 3 ). (cdc.gov)
- Over the last several years, Neisseria gonorrhoeae has developed decreased susceptibility to extended-spectrum cephalosporins worldwide. (bvsalud.org)
- These tests detected the presence of extended spectrum Beta lactamase enzymes and of carbapenemases (which hydrolyse wide-spectrum cephalosporins and carbapenems in Enterobacteriaceae and Pseudomonas aeruginosa, respectively). (unifr.ch)
- Of special concern is resistance to extended-spectrum cephalosporins, which are often used as empiric therapy for meningitis (3). (cdc.gov)
Carbapenems1
- Carbapenemases are a class of enzymes that can confer resistance to carbapenems and other Beta-lactam antibiotic drugs, but not all carbapenemase-producing isolates are carbapenem-resistant. (cdc.gov)
Infections13
- EXPERT OPINION A robust public health response is needed that includes better diagnosis and treatment of pharyngeal gonorrhea , improved surveillance of antimicrobial resistance, informed treatment approaches and reduction of the global burden of gonococcal infections . (bvsalud.org)
- Orally administered cephalosporins are beta-lactamic broad-spectrum antimicrobial agents that are often used empirically to treat community bacterial infections and also to treat culture-proven infections due to selected gram-positive and gram-negative microorganisms. (nih.gov)
- As a result, the report thirdgenerationcephalosporinsorfluoroquinolones, likely underestimates community-acquired but the WHO report indicates that resistance is infections, where resistance rates may vary. (who.int)
- Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. (medscape.com)
- Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, data summary from January 1996 through December 1997: A report from the National Nosocomial Infections Surveillance (NNIS) System. (medscape.com)
- In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). (medscape.com)
- Increasing antimicrobial resistance among pathogens causing complicated intra-abdominal infections (cIAIs) supports the development of new antimicrobials. (nih.gov)
- For example, in June 2019, Lupin Limited recalled 18,604 bottles (60 ml) of Cefdinir (Cephalosporin) for Oral Suspension, used for the treatment of bacterial infections, from the U.S. market. (giiresearch.com)
- Antibiotic resistance is a complication of treating patients in the intensive care unit (ICU) who have contracted healthcare-acquired infections (HAIs), but according to Marie-Laurence Lambert, MD, of the of the Scientific Institute of Public Health in Brussels, and colleagues, this resistance does not increase mortality. (infectioncontroltoday.com)
- The researchers conclude that healthcare-acquired bloodstream infections and pneumonia greatly increase mortality and pneumonia increases length of stay in intensive-care units, but that the additional effect of the most common antimicrobial resistance patterns is comparatively low. (infectioncontroltoday.com)
- Reference: Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I, Agodi A, Frank U, Mertens K, Schumacher M and Wolkewitz M. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. (infectioncontroltoday.com)
- It is a prescription drug which is used in the treatment and prevention of various bacterial infections Contra-indicated in patients with cephalosporin hypersensitivity. (seagullindia.com)
- Antibiotic resistance can turn once-manageable infections into 'superbug' diseases that are difficult-and sometimes impossible-to treat. (nih.gov)
Ceftriaxone8
- Chlamydia trachomatis ) and reflecting concern about emerging gonococcal resistance, CDC's 2010 sexually transmitted diseases (STDs) treatment guidelines recommended combination therapy for gonorrhea with a cephalosporin (ceftriaxone 250 mg intramuscularly or cefixime 400 mg orally) plus either azithromycin orally or doxycycline orally, even if nucleic acid amplification testing (NAAT) for C. trachomatis was negative at the time of treatment ( 2 ). (cdc.gov)
- Criteria for resistance to cefixime and ceftriaxone have not been defined by the Clinical Laboratory Standards Institute (CLSI). (cdc.gov)
- Gonococcal antimicrobial surveillance programs in multiple regions have documented the rise in N. gonorrhoeae isolates' minimum inhibitory concentrations to cephalosporins , and the first cases of ceftriaxone treatment failure have been reported. (bvsalud.org)
- One kind, ceftriaxone, is used if there is antibiotic resistance. (mayoclinic.org)
- We describe a multidrug-resistant Neisseria gonorrhoeae urethritis case with ceftriaxone resistance and azithromycin intermediate resistance in a heterosexual man in Ireland, August 2018. (eurosurveillance.org)
- IR72 was assigned MSLT ST1903, NG-MAST ST17842 and NG-STAR type 1133, including the ceftriaxone resistance-mediating penA- 60.001. (eurosurveillance.org)
- Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017. (eurosurveillance.org)
- The World Health Organization has warned that gonorrhea "may soon become untreatable" because of growing resistance to the antibiotic ceftriaxone, a member of the cephalosporin class. (raptureready.com)
Escherichia1
- Resistance was defined as resistance to ceftazidime (Acinetobacter baumannii or Pseudomonas aeruginosa), third-generation cephalosporins (Escherichia coli), and oxacillin (Staphylococcus aureus). (infectioncontroltoday.com)
Microorganisms1
- These habitats provide ideal conditions for bacteria from diverse sources, such as human sewage, animal waste and naturally occurring plant and soil microorganisms, to swap genes and spread antibiotic resistance, he notes. (nih.gov)
Susceptibility7
- None of the 26 Salmonella isolates with resistance or decreased susceptibility to ESCs produced ESBL, according to the double-disk synergy method ( 10 ). (cdc.gov)
- Among the 20 ESC-resistant isolates, 10 isolates were ciprofloxacin-resistant, 4 isolates showed decreased susceptibility to ciprofloxacin (MIC 0.25-1 μg/mL) and resistance to nalidixic acid, and 6 isolates were susceptible to ciprofloxacin and nalidixic acid ( Table 2 ). (cdc.gov)
- Antimicrobial susceptibility was tested by Vitek2™ Automated Susceptibility System and Etest™ strips, and whole-genome sequencing facilitated analysis of its multidrug resistance. (pacb.com)
- During September-December 2011, CDC and five external GISP principal investigators, each with N. gonorrhoeae -specific expertise in surveillance, antimicrobial resistance, treatment, and antimicrobial susceptibility testing, reviewed antimicrobial susceptibility trends in GISP through August 2011 to determine whether to update CDC's current recommendations ( 2 ) for treatment of uncomplicated gonorrhea. (cdc.gov)
- A variety of treatment strategies have been proposed in response to this 'superbug' threat, including increasing the dose or providing multiple doses of cephalosporins , multidrug therapy , rotating therapeutic regimens and individualized treatment based on susceptibility testing. (bvsalud.org)
- Majority of the strains were susceptibleto third generation cephalosporins.Conclusions: Enteric fever in India is caused by S. enterica serovar Typhi and S. enterica serovarParatyphi A. Nalidixic acid resistance is high among both S. enterica serovar Typhi and S. entericaserovar Paratyphi A. Susceptibility to ampicillin, chloramphenicol and cotrimoxazole is high. (who.int)
- Non-susceptibility of an organism to the action of the cephalosporins. (nih.gov)
Pseudomonas1
- Additionally, the IDSA recently published guidance for treating antimicrobial resistant gram negative pathogens with a focus on ESBL producing and carbapenem-resistant Enterobacterales as well as Pseudomonas aeruginosa with difficult to treat resistance patterns. (medscape.com)
Drug Resistance2
- Retrospective whole-genome sequencing analysis distinguished PFGE and drug-resistance-matched retail meat and clinical Salmonella isolates. (pacb.com)
- By better understanding the nature of drug resistance plasmids in urban wetlands, Cummings hopes to aid future efforts to prevent their potential spread among bacteria that cause human disease. (nih.gov)
Pathogens4
- Santajit S, Indrawattana N. Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens. (medscape.com)
- Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. (medscape.com)
- Within this context, bacterial pathogens may undergo rapid and dramatic evolution, facilitating host adaptation and the development of antibiotic resistance. (nih.gov)
- An entire series of bacterial pathogens have developed resistance to nearly every antibiotic. (raptureready.com)
Bacteria7
- The gene provides resistance to colistin, an antibiotic with nasty side effects used to combat multidrug-resistant bacteria. (scienceblogs.com)
- and Dr. Louise Francois Watkins, a Medical Officer, all with CDC's National Antimicrobial Resistance Monitoring System for Enteric Bacteria Team within the National Center for Emerging and Zoonotic Infectious Diseases. (cdc.gov)
- The emergence of antimicrobial resistance (AMR) in bacteria has been recognized as a critical threat to public health. (nih.gov)
- Similarly, most of the Gram negative bacteria showed resistance to cephalosporin, aminoglycosides. (banglajol.info)
- Bacteria living in the human body can trade resistance genes, too. (nih.gov)
- Gautam Dantas of Washington University School of Medicine in St. Louis is investigating how resistance develops in and spreads among the bacteria that colonize the human gut during the first 2 years of life. (nih.gov)
- This is a way to detect resistance genes before they [transfer into disease-causing bacteria and] become a problem,' says Dantas. (nih.gov)
Genes8
- Evolution of a clade of Acinetobacter baumannii global clone 1, lineage 1 via acquisition of carbapenem- and aminoglycoside-resistance genes and dispersion of ISAba1. (pacb.com)
- Here, we investigate the evolution of an expanding clade of lineage 1 of the GC1 complex via repeated acquisition of carbapenem- and aminoglycoside-resistance genes. (pacb.com)
- Part or all of the original resistance gene cluster in the chromosomally located AbaR3 has been lost from some isolates, but plasmids carrying alternate resistance genes have been gained. (pacb.com)
- Importantly, two copies of qnrVC6 gene with three ISCR1 around, a blaVIM-2 carrying integron In528, a novel gcu173 carrying integron In1348, and six antibiotic resistance genes were identified. (pacb.com)
- Fifteen resistance genes were identified across all isolates, including fosA7, a gene only recently found in a limited number of Salmonella and a =95? (pacb.com)
- David Cummings studies the role of urban storm water in spreading genes for antibiotic resistance in natural environments. (nih.gov)
- David Cummings of Point Loma Nazarene University in San Diego searches for plasmids bearing resistance genes in sediment samples from several urban wetlands. (nih.gov)
- Dantas is studying the development of the complete collection of resistance genes in the gut-dubbed the resistome-in healthy sets of twins and in infants with very low birthweights. (nih.gov)
Spectrum of activity1
- Cephalosporins differ widely in their spectrum of activity, in vitro antimicrobial potency, microbial resistance, pharmaco-kinetic properties and cost. (nih.gov)
Antibiotic resistance situation2
- Veterinarians, pet owners and breeders must all cooperate to improve the antibiotic resistance situation. (helsinki.fi)
- The data set aims to create awareness about antibiotic resistance situation and advocate AMR control policies in participating countries. (who.int)
Concern1
- Why is antimicrobial resistance a global concern? (who.int)
Ineffective1
- Data in the present study adds to the existing evidence that the use of cephalosporins such as cefovecin may be ineffective in many cases (intrinsic resistance of Enterococcus spp ) and therefore should be avoided unless cystocentesis and signalment results support their use. (vetclick.com)
Doses1
- If daily doses of Keflex greater than 4 g are required, parenteral cephalosporins, in appropriate doses, should be considered. (seagullindia.com)
Determinants2
- To assess its potential in enhancing integrated surveillance in Pennsylvania, USA, WGS was used to directly compare the genetic characteristics of 7 retail meat and 43 clinical historic Salmonella isolates, subdivided into 3 subsets based on PFGE and AST results, to retrospectively resolve their genetic relatedness and identify antimicrobial resistance (AMR) determinants. (pacb.com)
- We also discuss here different aspects critical to understand the success of MBLs in conferring resistance: the molecular determinants of their dissemination, their cell physiology, from the biogenesis to the processing involved in the transit to the periplasm, and the uptake of the Zn(II) ions upon metal starvation conditions, such as those encountered during an infection. (nih.gov)
Emergence3
- Widespread and uncontrolled use of these done on Mueller-Hinton agar (Oxoid) by drugs has, however, led to the emergence of the modified Kirby-Bauer disk diffusion resistance against them also [ 1-3 ]. (who.int)
- The development of the CarbAcineto test is an important contribution to the struggle against the emergence of antibiotic resistance. (unifr.ch)
- Here are just a few examples of what they're exploring and how it could aid efforts to curb the emergence of resistance. (nih.gov)
Third-generation1
- No resistance to third generation cephalosporins was detected. (who.int)
Nalidixic acid1
- Resistance to nalidixic acid was seen in 83% of the S. enterica serovarTyphi and 93% of S. enterica serovar Paratyphi A strains. (who.int)
Develop resistance1
- Gonorrhea treatment has been complicated by the ability of N. gonorrhoeae to develop resistance to antimicrobials used for treatment. (cdc.gov)
Neisseria1
- Effective treatment is a cornerstone of U.S. gonorrhea control efforts, but treatment of gonorrhea has been complicated by the ability of Neisseria gonorrhoeae to develop antimicrobial resistance. (cdc.gov)
Therapeutic1
- Therefore, therapeutic indication of a new cephalosporin is somewhat difficult to define, because the newer drugs must compete with improved properties over the previous ones. (nih.gov)
Empiric therapy1
- Resistance rates vary among different geographic regions and institutions, and some antibiotic regimens that were used in the past are no longer considered adequate for empiric therapy. (medscape.com)
Surveillance2
- This data set describes antimicrobial resistance (AMR) data from the WHO European Region gathered through the Central Asian and Eastern European Surveillance of Antimicrobial Resistance (CAESAR) network and the European Centre for Disease Prevention and Control (ECDC) European Antimicrobial Resistance Surveillance Network (EARS-Net). (who.int)
- Data from the European Antimicrobial Resistance Surveillance Network (EARS-Net). (who.int)
Clinical4
- Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance. (medscape.com)
- Mezzatesta ML, Gona F, Stefani S. Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance. (medscape.com)
- The rising number of clinical trials for R&D of cephalosporin drugs is also expected to boost the growth of the cephalosporin drugs market over the forecast period. (giiresearch.com)
- Level B data provides an indication of the resistance patterns present in clinical settings in the country, but the proportion of resistance should be interpreted with care. (who.int)
Patterns1
- Antimicrobial resistance patterns may vary. (medscape.com)
Methicillin2
- Methicillin resistance (MR) is being recognized with increased frequency in veterinary medicine and will have substantial impact on how we manage staphylococcal skin disease in the future. (vin.com)
- Methicillin resistance is reported in S. aureus (hospital or community acquired HA-MRSA & CA-MRSA), S. intermedius (MRSI), & S. schleiferi (MRSS). (vin.com)
Gonorrhea2
- The use of cephalosporins for gonorrhea: an update on the rising problem of resistance. (bvsalud.org)
- AREAS COVERED Since the publication of the last detailed review of the use of cephalosporins for gonorrhea in 2009, several new developments have occurred, which are detailed in this review . (bvsalud.org)
Various bacterial1
- However, various bacterial organisms have developed pesticide resistance such as kasugamycin resistance tested in Erwinia sp. (frontiersin.org)
Organisms1
- As a result, the last few decades have concernbyorganismandbyregion,mechanismsby witnessed a rapid development of resistance in which resistance is being developed, the potential common but deadly organisms such as S. aureus, K. economicandpatientimpactglobally,andstrategies pneumoniae, M. tuberculosis, and others. (who.int)
Mechanisms3
- A main area of focus within the Bacterial Pathogenesis and Antimicrobial Resistance Unit is the application of systems biology approaches to study the evolutionary mechanisms by which resistance emerges in this natural context. (nih.gov)
- Recent progress in characterizing molecular mechanisms of antimicrobial resistance has also made possible the development of new approaches to the detection of AMR based on proteomics and sequencing. (nih.gov)
- New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases, resulting in prolonged illness, disability, and death. (who.int)
Drugs5
- However, FLUTD is one of the most common reasons for the use of antimicrobial drugs in veterinary medicine and is therefore an important condition to consider to minimise antimicrobial use and development of antimicrobial resistance [ii] . (vetclick.com)
- The global cephalosporin drugs market size was valued US$ XX billion in 2019 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028). (giiresearch.com)
- Cephalosporin drugs are part of the beta-lactams group and they work by interfering with the synthesis of the bacterial cell wall. (giiresearch.com)
- Therefore, all these factors may help the cephalosporin drugs market witness fast growth over the forecast period. (giiresearch.com)
- Low platelet or red blood cell count Cephalexin is contraindicated in people who are allergic to cephalexin or any drug in the cephalosporin class of drugs. (seagullindia.com)
Treatment2
- Like many previous studies, the results also showed a link between antibiotic treatment and antibiotic resistance. (helsinki.fi)
- Head lice do not cause death, but its resistance to treatment shows the problem. (raptureready.com)
Gonorrhoeae1
- During the 1990s and 2000s, fluoroquinolone resistance in N. gonorrhoeae emerged in the United States, becoming prevalent in Hawaii and California and among men who have sex with men (MSM) before spreading throughout the United States. (cdc.gov)
Data2
- recent data has indeed shown that the cephalosporin cefovecin is a commonly prescribed antibiotic [iii] for cats presenting with lower urinary tract disease. (vetclick.com)
- Data has been collected by the Control of Antimicrobial Resistance Programme at the Division of Health Emergencies and Communicable Diseases, World Health Organization Regional Office for Europe and the ECDC EARS-Net. (who.int)
Azithromycin1
- One kind called azithromycin (Zithromax) can be used if there is antibiotic resistance. (mayoclinic.org)
Bacterium1
- One of the few bright spots regarding the problem of antibiotic resistance is that resistance typically infers a fitness cost to the bacterium, at least initially. (scienceblogs.com)
Group1
- In one group in subclade 2, the chromosomally located AbGRI3, carrying the armA aminoglycoside-resistance gene, has been acquired from a GC2 isolate and incorporated via homologous recombination. (pacb.com)